AAC
AAC, licence 80057240: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- A.A.C. - Acute Allergy Control, Master Formulae - Mystic Air, NaturTech Labs Inc - AAC
- Licence holder
- Natures Formulae Health Products Ltd.
- NPN or DIN-HM
- 80057240
- Status
- Active licence
- Licence date
- 13 January 2015
- Revision date
- Not provided
- Form
- Vaporisateur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Plectranthus barbatus Source : Racine Extract : Matériel brut sec Extraction ratio : 1.0:5.0 Dry plant equivalent : 0.001365 mg | 0.006825 mg | Not calculated |
| Urtica dioica Source : Sommité en fleurs (herbe) Extract : Matériel brut sec Extraction ratio : 1.0:2.0 Dry plant equivalent : 0.0437 mg | 0.0874 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 1:4.008 Dry plant equivalent : 0.0131 mg Potency : 25.0 % Flavonoid glycosides | 0.0525 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 5.0 % Terpene lactones | Not specified | Not calculated |
Non-medicinal ingredients
Eau purifiée, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 7.0 Pulvérisateur | minimum: 4.0 Jour(s) ; maximum: 6.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve seasonal allergy symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057240
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.